Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
2025;8(1):e2457349
Retatrutide is an investigational medicine currently under clinical development for the treatment of obesity and related metabolic conditions
The large share of this segment can be attributed to the growing adoption of Ozempic (semaglutide), The diabetes segment dominated the overall GLP-1 agonists market in 2024
We use both session and persistent Cookies for the purposes set out below: The Company may use Personal Data for the following purposes: We may disclose your personal information in any other way so long as it is with your consent and/or for any other purpose disclosed by Us when You provide the information
US$ 23.47
US$ 21.31
.png)
US$ 27.46
US$ 20.39
US$ 22.18
US$ 20.95
